Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

HUNGER

Showing results (1011-1020 of 1,174) with videos related to

Pageof 118
Sort By:
Blood|May 13, 2011
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology GroupYousif Matloub, Bruce C Bostrom, Stephen P Hunger, et al.
Pediatric Blood & Cancer|February 9, 2021
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology GroupRachel E Rau, Yunfeng Dai, Meenakshi Devidas, et al.
Pediatric Blood & Cancer|August 17, 2023
Assessment of proxy-reported responses as predictors of motor and sensory peripheral neuropathy in children with B-lymphoblastic leukemiaRozalyn L Rodwin, Natalie J DelRocco, Emily Hibbitts, et al.
Leukemia|January 21, 2014
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031K R Schultz, A Carroll, N A Heerema, et al.
Journal of the National Cancer Institute|September 4, 2020
Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in ChildrenShawn H R Lee, Maoxiang Qian, Wentao Yang, et al.
Blood|September 1, 2011
The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Alex Kentsis, Takaomi Sanda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]Deepa Bhojwani, Huining Kang, Renee X Menezes, et al.
The New England Journal of Medicine|April 13, 2012
Outcomes after induction failure in childhood acute lymphoblastic leukemiaMartin Schrappe, Stephen P Hunger, Ching-Hon Pui, et al.
NAR Cancer|December 15, 2022
A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1Adria Closa, Marina Reixachs-Solé, Antonio C Fuentes-Fayos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group studyKirk R Schultz, W Paul Bowman, Alexander Aledo, et al.
Pageof 118

Showing results (1011-1020 of 1,174) with videos related to

Sort By:
Pageof 118
Blood|May 13, 2011
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology GroupYousif Matloub, Bruce C Bostrom, Stephen P Hunger, et al.
Pediatric Blood & Cancer|February 9, 2021
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology GroupRachel E Rau, Yunfeng Dai, Meenakshi Devidas, et al.
Pediatric Blood & Cancer|August 17, 2023
Assessment of proxy-reported responses as predictors of motor and sensory peripheral neuropathy in children with B-lymphoblastic leukemiaRozalyn L Rodwin, Natalie J DelRocco, Emily Hibbitts, et al.
Leukemia|January 21, 2014
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031K R Schultz, A Carroll, N A Heerema, et al.
Journal of the National Cancer Institute|September 4, 2020
Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in ChildrenShawn H R Lee, Maoxiang Qian, Wentao Yang, et al.
Blood|September 1, 2011
The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Alex Kentsis, Takaomi Sanda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]Deepa Bhojwani, Huining Kang, Renee X Menezes, et al.
The New England Journal of Medicine|April 13, 2012
Outcomes after induction failure in childhood acute lymphoblastic leukemiaMartin Schrappe, Stephen P Hunger, Ching-Hon Pui, et al.
NAR Cancer|December 15, 2022
A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1Adria Closa, Marina Reixachs-Solé, Antonio C Fuentes-Fayos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group studyKirk R Schultz, W Paul Bowman, Alexander Aledo, et al.
Pageof 118